Baihua Pharmaceutical (600721)
Overview
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd engages in pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses. It also offers comprehensive contract research organization (CRO) solutions, including one-stop, full-process services for drug R&D, such as Phase I to IV clinical trials, bioequivalence and pharmacokinetics testing, medical science services, R&D project consulting, data management and statistical services, and third-party testing
Employees672
Market Cap$2.7B
Revenue$358.6M
Listed OnShanghai Stock Exchange
Ticker600721
CEOMr. Hui Huang
HeadquartersUrumqi